TS
NVAX icon

Thomas Steyer’s Novavax NVAX Stock Holding History

Thomas Steyer’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,000
Closed -$179K – 155
2026
Q1 		$179K Sell
22,000
-173,000
-89% -$1.57M ﹤0.01% 152
2025
Q4 		$1.31M Sell
195,000
-585,000
-75% -$4.41M 0.01% 82
2025
Q3 		$6.76M Buy
780,000
+764,000
+4,775% +$5.95M 0.03% 78
2025
Q2 		$101K Hold
16,000
– – ﹤0.01% 130
2025
Q1 		$103K Hold
16,000
– – ﹤0.01% 135
2024
Q4 		$129K Hold
16,000
– – ﹤0.01% 141
2024
Q3 		$202K Sell
16,000
-361,250
-96% -$4.66M ﹤0.01% 142
2024
Q2 		$4.78M Sell
377,250
-753,750
-67% -$7.58M 0.02% 93
2024
Q1 		$5.41M Buy
+1,131,000
New +$5.25M 0.02% 100
2022
Q3 		– Sell
-498,000
Closed -$25.6M – 317
2022
Q2 		$25.6M Buy
+498,000
New +$25.8M 0.14% 88
2021
Q4 		– Sell
-83,713
Closed -$17.4M – 311
2021
Q3 		$17.4M Buy
83,713
+43,713
+109% +$9.63M 0.08% 112
2021
Q2 		$8.49M Sell
40,000
-135,000
-77% -$24.7M 0.03% 142
2021
Q1 		$31.7M Sell
175,000
-100,000
-36% -$19.9M 0.16% 85
2020
Q4 		$30.7M Buy
+275,000
New +$29.2M 0.18% 79

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Thomas Steyer's NVAX Position: Q2 2026 in Review

Thomas Steyer sold out of Novavax (NVAX) in Q2 2026, closing a stake of 22,000 shares — an estimated $179K sold.

Thomas Steyer first reported a position in NVAX in Q4 2020 and held it in 14 quarters. The position peaked at $31.7M in Q1 2021. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Thomas Steyer reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 22,000 Novavax shares in Q2 2026, an estimated $179K.
  • Thomas Steyer first reported a position in Novavax in Q4 2020 and held it in 14 quarters.
  • Thomas Steyer's Novavax position peaked at $31.7M in Q1 2021.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.